| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 160.68M | 420.57M | 390.63M | 378.48M | 267.95M | 260.59M |
| Gross Profit | 81.28M | 219.23M | 209.08M | 219.64M | 144.85M | 132.63M |
| EBITDA | -214.40M | -50.52M | 154.60M | 167.29M | 103.22M | 93.87M |
| Net Income | -216.66M | -53.72M | 19.24M | 18.66M | 3.15M | 77.81M |
Balance Sheet | ||||||
| Total Assets | 505.48M | 473.92M | 201.04M | 162.94M | 131.35M | 81.36M |
| Cash, Cash Equivalents and Short-Term Investments | 127.36M | 77.46M | 41.22M | 13.64M | 21.94M | 13.42M |
| Total Debt | 0.00 | 201.64M | 344.64M | 367.61M | 393.36M | 255.89M |
| Total Liabilities | 353.01M | 617.36M | 406.81M | 454.94M | 539.00M | 273.91M |
| Stockholders Equity | 152.47M | -143.45M | -802.36M | -892.23M | -1.02B | -192.55M |
Cash Flow | ||||||
| Free Cash Flow | 23.20M | 122.14M | 93.37M | 83.73M | 73.03M | 79.56M |
| Operating Cash Flow | 26.52M | 129.55M | 104.31M | 92.78M | 77.78M | 87.06M |
| Investing Cash Flow | -65.12M | -9.95M | -10.94M | -9.05M | -4.75M | -7.50M |
| Financing Cash Flow | 113.29M | -83.36M | -65.79M | -92.03M | -64.51M | -92.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $3.30B | 10.56 | 27.28% | 0.67% | 1.55% | 701.41% | |
73 Outperform | $631.23M | 15.50 | 11.36% | 3.37% | 22.39% | 112.75% | |
71 Outperform | $2.84B | 26.74 | 11.50% | 1.21% | -39.38% | 175.22% | |
70 Outperform | $1.14B | 78.80 | 2.21% | ― | 2.82% | -34.29% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $386.25M | 32.76 | 5.06% | ― | -12.38% | -0.71% | |
57 Neutral | $2.56B | ― | ― | ― | -61.71% | -622.81% |
On November 2, 2025, CompoSecure, Inc. entered into a Share Purchase Agreement with Husky Technologies Limited and other parties, involving a combination valued at approximately $3.953 billion in cash and shares. Concurrently, CompoSecure agreed to a private placement of shares for about $1.96 billion. The company has faced legal challenges from shareholders alleging incomplete and misleading information in its Proxy Statement, which could affect the approval of the transaction at the upcoming special meeting on December 23, 2025. To mitigate risks and costs of litigation, CompoSecure has decided to voluntarily supplement the Proxy Statement, although it denies any wrongdoing.
On November 2, 2025, CompoSecure, Inc. announced a Share Purchase Agreement with Husky Technologies Limited and its affiliates, valued at approximately $3.953 billion in cash and shares. This transaction will result in Husky becoming an indirect wholly owned subsidiary of CompoSecure. The agreement is subject to several closing conditions, including shareholder approval and regulatory clearances. The transaction is expected to enhance CompoSecure’s market position and operational capabilities, with potential implications for stakeholders, such as changes in the company’s board and management agreements.
On November 3, 2025, CompoSecure, Inc. announced the redemption of all its outstanding public warrants to purchase shares of its Class A common stock. The redemption date is set for December 3, 2025, and warrant holders have until that date to exercise their warrants on a cashless basis. Any unexercised warrants will be canceled, and holders will receive $0.01 per warrant. This move follows the company’s right to redeem the warrants as the stock price met certain criteria, potentially impacting stakeholders by altering their rights and investment strategies.
On November 3, 2025, CompoSecure announced its strong financial results for the third quarter of 2025, with significant growth in net sales and gross profit compared to the previous year. The company also revealed a business combination with Husky Technologies, a manufacturer of engineered equipment, valuing the combined entity at approximately $7.4 billion. This strategic move aims to enhance CompoSecure’s market position and create new opportunities for growth. The transaction is expected to close in the first quarter of 2026 and is anticipated to be accretive to earnings per share in the first full year post-closing.